Business Description
Vir Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : US92764N1028
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.22 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.19 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.67 | |||||
Beneish M-Score | -9.64 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.5 | |||||
3-Year EBITDA Growth Rate | -26.5 | |||||
3-Year EPS without NRI Growth Rate | -20.8 | |||||
3-Year FCF Growth Rate | -53.3 | |||||
3-Year Book Growth Rate | 28 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.27 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -59.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.05 | |||||
Quick Ratio | 9.05 | |||||
Cash Ratio | 8.68 | |||||
Days Payable | 1079.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.9 | |||||
Shareholder Yield % | 0.41 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93 | |||||
Operating Margin % | -1732.68 | |||||
Net Margin % | -1557.35 | |||||
FCF Margin % | -1901.87 | |||||
ROE % | -33.7 | |||||
ROA % | -26.34 | |||||
ROIC % | -200.09 | |||||
ROC (Joel Greenblatt) % | -383.74 | |||||
ROCE % | -33.83 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 27.56 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.71 | |||||
EV-to-EBIT | 0.43 | |||||
EV-to-EBITDA | 0.44 | |||||
EV-to-Forward-EBITDA | -9.13 | |||||
EV-to-Revenue | -7.43 | |||||
EV-to-Forward-Revenue | 2.12 | |||||
EV-to-FCF | 0.37 | |||||
Price-to-Net-Current-Asset-Value | 0.87 | |||||
Price-to-Net-Cash | 0.92 | |||||
Earnings Yield (Greenblatt) % | 232.56 | |||||
FCF Yield % | -72.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vir Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 733.821 | ||
EPS (TTM) (MXN) | -80.392 | ||
Beta | 0 | ||
Volatility % | 59.05 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0.000147 | ||
20-Day SMA (MXN) | 172 | ||
12-1 Month Momentum % | -59.05 | ||
52-Week Range (MXN) | 172 - 420 | ||
Shares Outstanding (Mil) | 135.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vir Biotechnology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vir Biotechnology Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Vir Biotechnology Inc Frequently Asked Questions
What is Vir Biotechnology Inc(MEX:VIR)'s stock price today?
When is next earnings date of Vir Biotechnology Inc(MEX:VIR)?
Does Vir Biotechnology Inc(MEX:VIR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |